These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 8025348)

  • 1. Antiphospholipid antibodies: specificity and pathophysiology.
    de Groot PG; Oosting JD; Derksen RH
    Baillieres Clin Haematol; 1993 Sep; 6(3):691-709. PubMed ID: 8025348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid antibodies and thrombosis.
    Brighton TA; Chesterman CN
    Baillieres Clin Haematol; 1994 Sep; 7(3):541-57. PubMed ID: 7841600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies.
    Galli M; Finazzi G; Bevers EM; Barbui T
    Blood; 1995 Jul; 86(2):617-23. PubMed ID: 7605991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins.
    Bertolaccini ML; Hughes GR; Khamashta MA
    Clin Lab; 2004; 50(11-12):653-65. PubMed ID: 15575307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiphospholipid antibodies: clinical significance and biological diagnosis].
    Arnoux D; Boutière B; Sanmarco M
    Ann Biol Clin (Paris); 2000; 58(5):557-74. PubMed ID: 11022099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of antiphospholipid antibodies].
    Atsumi T; Koike T
    Rinsho Byori; 1998 Apr; 46(4):297-302. PubMed ID: 9594618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel considerations in the pathogenesis of the antiphospholipid syndrome: involvement of the tissue factor pathway of blood coagulation.
    Adams M
    Semin Thromb Hemost; 2008 Apr; 34(3):251-5. PubMed ID: 18720304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid antibodies: basic immunology and assays.
    Schultz DR
    Semin Arthritis Rheum; 1997 Apr; 26(5):724-39. PubMed ID: 9144849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies.
    Roubey RA
    Blood; 1994 Nov; 84(9):2854-67. PubMed ID: 7949161
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lupus anticoagulants versus antiphospholipid antibodies].
    Pereira MI
    Acta Med Port; 1998 Apr; 11(4):349-57. PubMed ID: 9644846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis and treatment of the antiphospholipid antibody syndrome.
    Petri M
    Med Clin North Am; 1997 Jan; 81(1):151-77. PubMed ID: 9012759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiphospholipid syndrome].
    Atsumi T; Koike T
    Nihon Rinsho; 1998 Jan; 56(1):215-23. PubMed ID: 9465693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?
    Oosting JD; Derksen RH; Bobbink IW; Hackeng TM; Bouma BN; de Groot PG
    Blood; 1993 May; 81(10):2618-25. PubMed ID: 8166780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrovascular disease with antiphospholipid antibodies: immune mechanisms, significance, and therapeutic options.
    Feldmann E; Levine SR
    Ann Neurol; 1995 May; 37 Suppl 1():S114-30. PubMed ID: 8968222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor V Leiden and antibodies against phospholipids and protein S in a young woman with recurrent thromboses and abortion.
    España F; Villa P; Mira Y; Grancha S; Royo M; Estellés A; Vayá A; Aznar J
    Haematologica; 1999 Jan; 84(1):80-4. PubMed ID: 10091395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibody explosion in antiphospholipid syndrome.
    Shoenfeld Y; Twig G; Katz U; Sherer Y
    J Autoimmun; 2008; 30(1-2):74-83. PubMed ID: 18171610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protean clinical presentation of antiphospholipid-protein antibodies (APA).
    Triplett DA
    Thromb Haemost; 1995 Jul; 74(1):329-37. PubMed ID: 8578480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New targets of antiphospholipid antibodies].
    Arvieux J; Darnige L; Sarrot-Reynauld F
    Rev Med Interne; 1997; 18(4):292-302. PubMed ID: 9161556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.